使用华法林或直接口服抗凝药患者治疗性内镜相关消化道出血与血栓栓塞事件:基于全国大型数据库分析的结果
基于日本诊断程序组合数据库2014至2015年16977例接受13种高风险内镜操作且术前服用华法林或直接口服抗凝药(DOAC)的患者,倾向性评分1:1匹配后5046对分析显示,华法林组消化道出血比例显著高于DOAC组(12.0% vs 9.9%;p=0.002),血栓栓塞(5.4% vs 4.7%)与院内死亡(5.4% vs 4.7%)无显著差异;华法林加肝素桥接或DOAC加桥接者出血与血栓栓塞风险均高于单用DOAC者;出血风险随内镜操作类型而异。
要点
- 华法林组内镜后消化道出血比例显著高于DOAC组(12.0% vs 9.9%;p=0.002)。
- 两组血栓栓塞(5.4% vs 4.7%)与院内死亡(5.4% vs 4.7%)无显著差异。
- 华法林加肝素桥接或DOAC加桥接者出血与血栓栓塞风险均高于单用DOAC者。
核心结论
- 内镜后消化道出血风险华法林使用者高于DOAC使用者。
- 肝素桥接与出血风险增加相关,且未预防血栓栓塞。
- 出血风险因内镜操作类型而异。
研究设计与样本
- 利用日本诊断程序组合数据库,识别2014至2015年接受13种高风险内镜操作且术前服用华法林或DOAC的患者16977例。
- 采用1:1倾向性评分匹配比较华法林组与DOAC组内镜后消化道出血与血栓栓塞。
主要发现
- 倾向性评分匹配分析纳入5046对,华法林组消化道出血比例显著高于DOAC组(12.0% vs 9.9%;p=0.002)。
- 血栓栓塞(5.4% vs 4.7%)与院内死亡(5.4% vs 4.7%)无显著差异。
- 华法林加肝素桥接或DOAC加桥接者出血与血栓栓塞风险均高于单用DOAC者。
- 与经皮内镜下胃造瘘相比,内镜黏膜下剥离术、内镜黏膜切除术及包括内镜套扎术或内镜注射硬化术的止血操作在13种内镜操作中消化道出血风险最高,而低位息肉切除术、内镜括约肌切开术或内镜超声引导细针穿刺抽吸者风险中等。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To compare the risks of postendoscopy outcomes associated with warfarin with direct oral anticoagulants (DOACs), taking into account heparin bridging and various types of endoscopic procedures. DESIGN: Using the Japanese Diagnosis Procedure Combination database, we identified 16 977 patients who underwent 13 types of high-risk endoscopic procedures and took preoperative warfarin or DOACs from 2014 to 2015. One-to-one propensity score matching was performed to compare postendoscopy GI bleeding and thromboembolism between the warfarin and DOAC groups. RESULTS: In the propensity score-matched analysis involving 5046 pairs, the warfarin group had a significantly higher proportion of GI bleeding than the DOAC group (12.0% vs 9.9%; p=0.002). No significant difference was observed in thromboembolism (5.4% vs 4.7%) or in-hospital mortality (5.4% vs 4.7%). The risks of GI bleeding and thromboembolism were greater in patients treated with warfarin plus heparin bridging or DOACs plus bridging than in patients treated with DOACs alone. Compared with percutaneous endoscopic gastrostomy, patients who underwent endoscopic submucosal dissection, endoscopic mucosal resection and haemostatic procedures including endoscopic variceal ligation or endoscopic injection sclerotherapy were at the highest risk of GI bleeding among the 13 types of endoscopic procedures, whereas those who underwent lower polypectomy endoscopic sphincterotomy or endoscopic ultrasound-guided fine needle aspiration were at moderate risk. CONCLUSION: The risk of postendoscopy GI bleeding was higher in warfarin than DOAC users. Heparin bridging was associated with an increased risk of bleeding and did not prevent thromboembolism. The bleeding risk varied by the type of endoscopic procedure.
引用
- Nagata N, Yasunaga H, Matsui H, et al. Therapeutic endoscopy-related GI bleeding and thromboembolic events in patients using warfarin or direct oral anticoagulants: results from a large nationwide database analysis. Gut. 2017. PMID: 28874418. doi:10.1136/gutjnl-2017-313999
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。